COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory and cardiovascular disease areas and wound healing, announced today that Stephen Potter, Senior Vice President of Operations and Corporate Development, is scheduled to present at the Sixth Annual JMP Securities Healthcare Conference on Tuesday, September 27, 2011 at 3:30 p.m. ET in New York City.
